Overview

Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1

Status:
Terminated
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The study will examine the effect of HAL vs placebo photodynamic therapy of low-grade cervical precancerous lesions (dysplasia) in women.
Phase:
Phase 2
Details
Lead Sponsor:
Photocure
Treatments:
Aminolevulinic Acid